Chronic renal failure, dialysis, and renal transplantation in Anderson-Fabry disease.
نویسندگان
چکیده
Anderson-Fabry disease (AFd) is a rare, inherited, x-linked disease characterized by the deficiency of the lysosomal enzymatic alpha-galactosidase A activity (alpha-Gal-A). The enzyme defect leads to progressive accumulation of glycosphingolipids (GL) in all kinds of cells, tissues, organs, and body fluids. The clinical manifestations are very protean, the residual activity of alpha-Gal-A and/or different gene mutations might explain different phenotypes, but as yet these concepts have not been proven. Usually, patients with AFd show 3 clinical phases, more evident in men than in heterozygous women. The first phase (childhood and adolescence) is characterized by myalgia, arthralgia, acroparesthesia, fever, cutaneous angiokeratomas, and corneal opacities. The second phase is characterized mainly by renal involvement. In the third phase, severe renal impairment and involvement of cerebrovascular and cardiovascular systems are present. The progression to end-stage renal disease (ESRD) is common in hemizygous males (3rd-5th decade of life); usually, death occurs because of cerebral and/or cardiovascular complications in patients undergoing chronic dialysis therapies. The survival of patients with AFd in dialysis is better than in diabetic patients, but it clearly is decreased compared with uremic patients with other nephropathies, despite a lower mean age of uremia (50 versus 60 y). The outcome of kidney transplantation is similar to that found in other patients with ESRD, despite controversial issues published in the past. The use of a kidney donor with normal alpha-Gal-A activity in the control of the metabolic systemic disease is unproven. The recurrence of GL deposits in the kidney graft has been documented rarely. The definitive treatment for AFd is enzyme replacement therapy with purified alpha-Gal-A produced by a genetically engineered human cell line or Chinese hamster oocytes: relatively short-term studies have shown a significant treatment effect on clinical outcome measures.
منابع مشابه
بررسی تأثیر یک نوبت همودیالیز بر میزان کسر جهشی بطن چپ در بیماران مبتلا به نارسایی مزمن کلیه
Cardiovascular system is severely influenced with chronic renal failure. Although dialysis and renal transplantation have been improved the survival of the patients with chronic renal failure in past 30 years, but cardiovascular disease is the most common cause of their death yet. Dialysis could regress many of the changes accompanied with chronic renal failure,...
متن کاملCharacteristics of Dialysis Patients in Hemodialysis Centers in Isfahan
Background: Chronic kidney disease is a health problem in today’s world and hemodialysis is an alternative method for patients with chronic renal failure. Preparing provincial and national information on the situation of patients can play a significant role in improving the quality of services provided to patients undergoing hemodialysis. Objective: This ...
متن کاملRenal transplantation outcome in children with cystinosis
Background and Objective: Cystinosis is a rare inherited disease that leads to renal failure. Fanconi syndrome is the major renal involvement in cystinosis patients. Renal transplantation is the treatment of choice in cystinosis children with end-stage renal disease (ESRD). The study aimed to assess the outcome of renal transplantation in Iranian children with cystinosis. Methods: This...
متن کاملEnd-stage renal disease in patients with Fabry disease.
Anderson-Fabry disease (AFD) is a rare cause of end-stage renal disease (ESRD). Renal pathology in AFD is notable for diffuse deposition of glycosphingolipid in the renal glomeruli, tubules, and vasculature. Light microscopic findings include a “foamy” appearance of the glomeruli with diffuse swelling and vacuolization of visceral podocytes. Electron microscopic findings show podocytes and mesa...
متن کاملALUMINUM TOXICITY: A REVIEW IN RELATION TO CHRONIC RENAL FAILURE PATIENTS M AINTAINED ON REGULAR HEMODIALYSIS
Aluminum is present in very small amounts in living organisms but abundant in the environment. A growing literature links with the biochemistry of aluminum and also with a series of diseases in chronic renal failure patients on treatment with hemodialysis. The initial description of potential aluminum toxicity in renal failure patients relates to description of dialysis encephalopathy syndr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Seminars in nephrology
دوره 24 5 شماره
صفحات -
تاریخ انتشار 2004